Daniel Bernabéu

Pazopanib for treatment of advanced malignant and dedifferentiated solitary fibrous tumour: a multicentre, single-arm, phase 2 trial

Javier Martín‐Broto, Silvia Stacchiotti, Antonio López–Pousa et al. · The Lancet Oncology · 2018 · 131 citations

Surgical Oncology, Medicine, Metronomic Therapy +5

Pazopanib for treatment of typical solitary fibrous tumours: a multicentre, single-arm, phase 2 trial

Javier Martín‐Broto, Josefina Cruz, Nicolas Penel et al. · The Lancet Oncology · 2020 · 84 citations

Surgical Oncology, Medicine, Systemic Treatment +5

Pazopanib for treatment of advanced extraskeletal myxoid chondrosarcoma: a multicentre, single-arm, phase 2 trial

Silvia Stacchiotti, Stefano Ferrari, Andrés Redondo et al. · The Lancet Oncology · 2019 · 79 citations

Medicine, Orthopaedic Surgery, Surgery

Malignant bone tumors (other than Ewing’s): clinical practice guidelines for diagnosis, treatment and follow-up by Spanish Group for Research on Sarcomas (GEIS)

Andrés Redondo, Sílvia Bagué, Daniel Bernabéu et al. · Cancer Chemotherapy and Pharmacology · 2017 · 46 citations · Full text

Prognostic value of neutrophil-to-lymphocyte ratio and other inflammatory markers in patients with high-risk soft tissue sarcomas

D. Viñal, D. Martínez, J. A. Garcia-Cuesta et al. · Clinical & Translational Oncology · 2020 · 26 citations

Inflammation, Granulocyte, Prognostic Value +9